Therapeutic Drug Monitoring of Ganciclovir: Where Are We?

Ganciclovir is the mainstay of therapy for the prophylaxis and treatment of Cytomegalovirus. However, therapy with this antiviral agent is hindered by side effects such as myelosuppression, which often leads to therapy cessation. Underdosing, as an attempt to prevent side effects, can lead to drug r...

Celý popis

Podrobná bibliografia

Vydané v:	Therapeutic drug monitoring Ročník 44; číslo 1; s. 138
Hlavní autori:	Märtson, Anne-Grete, Edwina, Angela E, Kim, Hannah Yejin, Knoester, Marjolein, Touw, Daan J, Sturkenboom, Marieke G G, Alffenaar, Jan-Willem C
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.02.2022
Predmet:	Antiviral Agents - adverse effects Cytomegalovirus Infections - drug therapy Drug Monitoring - methods Ganciclovir - therapeutic use Humans Valganciclovir - pharmacokinetics Valganciclovir - therapeutic use
ISSN:	1536-3694, 1536-3694
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!